Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
Aveanna Healthcare Holdings, Inc. (AVAH)
Shaner Jeff — Chief Executive Officer
Shares
119,884
Price
$7.65
Total Value
$916.53K
Shares Held After
2,992,917
% of Holdings
3.9%
Aveanna Healthcare Holdings, Inc. (AVAH)
Buckhalter Matthew — Chief Financial Officer
Shares
9,351
Price
$7.65
Total Value
$71.49K
Shares Held After
555,922
% of Holdings
1.7%
Aveanna Healthcare Holdings, Inc. (AVAH)
Cunningham Patrick A. — Chief Compliance Officer
Shares
12,759
Price
$7.65
Total Value
$97.54K
Shares Held After
374,156
% of Holdings
3.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
Stewart Deborah — SVP, Chief Accounting Officer
Shares
7,738
Price
$7.65
Total Value
$59.16K
Shares Held After
323,884
% of Holdings
2.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
Reisz Edwin C. — Chief Administrative Officer
Shares
42,057
Price
$7.65
Total Value
$321.53K
Shares Held After
1,567,043
% of Holdings
2.6%
Outset Medical, Inc. (OM)
Brottem John L. — General Counsel
Shares
2,842
Price
$3.35
Total Value
$9.52K
Shares Held After
32,935
% of Holdings
7.9%
Outset Medical, Inc. (OM)
Trigg Leslie — Director
Shares
3,361
Price
$3.35
Total Value
$11.26K
Shares Held After
102,342
% of Holdings
3.2%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
200
Price
$103.84
Total Value
$20.77K
Shares Held After
114,897
% of Holdings
0.2%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,069
Price
$103.00
Total Value
$110.11K
Shares Held After
115,097
% of Holdings
0.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
900
Price
$101.70
Total Value
$91.53K
Shares Held After
116,166
% of Holdings
0.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
200
Price
$100.52
Total Value
$20.10K
Shares Held After
117,066
% of Holdings
0.2%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
1,200
Price
$99.42
Total Value
$119.30K
Shares Held After
117,266
% of Holdings
1.0%
Outset Medical, Inc. (OM)
Nash Marc — EVP Operations R&D & Service
Shares
1,817
Price
$3.35
Total Value
$6.09K
Shares Held After
39,988
% of Holdings
4.3%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Farmer Michele — See Remarks
Shares
35,215
Price
$1.58
Total Value
$55.50K
Shares Held After
234,044
% of Holdings
13.1%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Van Oene Mark — See Remarks
Shares
129,790
Price
$1.58
Total Value
$204.55K
Shares Held After
1,797,745
% of Holdings
6.7%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
HENRY CHRISTIAN O — See Remarks
Shares
331,793
Price
$1.58
Total Value
$522.91K
Shares Held After
2,814,374
% of Holdings
10.5%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
2,200
Price
$29.59
Total Value
$65.11K
Shares Held After
387,075
% of Holdings
0.6%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
5,400
Price
$28.95
Total Value
$156.33K
Shares Held After
389,275
% of Holdings
1.4%
Rapport Therapeutics, Inc. (RAPP)
Bredt David — Chief Scientific Officer
Shares
900
Price
$28.02
Total Value
$25.22K
Shares Held After
394,675
% of Holdings
0.2%
EXELIXIS, INC. (EXEL)
Smith Julie — Director
Shares
42,422
Price
$43.33
Total Value
$1.84M
Shares Held After
20,590
% of Holdings
67.3%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
45,000
Price
$26.17
Total Value
$1.18M
Shares Held After
25,000
% of Holdings
64.3%
Enliven Therapeutics, Inc. (ELVN)
Heyman Richard A. — Director
Shares
1,230
Price
$26.18
Total Value
$32.20K
Shares Held After
22,647
% of Holdings
5.2%
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
40
Price
$629.86
Total Value
$25.19K
Shares Held After
12,693
% of Holdings
0.3%
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
689
Price
$629.09
Total Value
$433.44K
Shares Held After
12,733
% of Holdings
5.1%
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
2,694
Price
$628.22
Total Value
$1.69M
Shares Held After
13,422
% of Holdings
16.7%
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
1,288
Price
$626.26
Total Value
$806.62K
Shares Held After
16,116
% of Holdings
7.4%
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
204
Price
$625.24
Total Value
$127.55K
Shares Held After
17,404
% of Holdings
1.2%
IDEXX LABORATORIES INC /DE (IDXX)
Erickson Michael G — Executive Vice President
Shares
456
Price
$623.76
Total Value
$284.43K
Shares Held After
17,608
% of Holdings
2.5%
IDEXX LABORATORIES INC /DE (IDXX)
Vandebroek Sophie V. — Director
Shares
519
Price
$628.56
Total Value
$326.22K
Shares Held After
648
% of Holdings
44.5%
IDEXX LABORATORIES INC /DE (IDXX)
Vandebroek Sophie V. — Director
Shares
945
Price
$628.65
Total Value
$594.07K
Shares Held After
1,167
% of Holdings
44.7%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
2
Price
$70.13
Total Value
$140.26
Shares Held After
111,312
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
2,811
Price
$69.29
Total Value
$194.77K
Shares Held After
111,314
% of Holdings
2.5%
Gemini Therapeutics, Inc. (GMTX)
Franchi Jean M. — Chief Financial Officer
Shares
4,075
Price
$62.86
Total Value
$256.15K
Shares Held After
78,424
% of Holdings
4.9%
Bio-Techne Corporation (TECH)
Herr Amy E. — Director
Shares
1,976
Price
$59.10
Total Value
$116.79K
Shares Held After
200
% of Holdings
90.8%
NATIONAL RESEARCH CORP (NRC)
HARRISON SHANE R — EVP & Chief Financial Officer
Shares
8,000
Price
$12.27
Total Value
$98.16K
Shares Held After
8,000
% of Holdings
100.0%
Neumora Therapeutics, Inc. Common Stock (NMRA)
Milligan Michael Lee — Title: Chief Financial Officer & Principal Accounting Officer
Shares
1,436
Price
$3.56
Total Value
$5.12K
Shares Held After
21,034
% of Holdings
6.4%
Neumora Therapeutics, Inc. Common Stock (NMRA)
BERNS PAUL L — Director
Shares
9,819
Price
$3.51
Total Value
$34.46K
Shares Held After
7,395,185
% of Holdings
0.1%
Neumora Therapeutics, Inc. Common Stock (NMRA)
Pinto Joshua — President
Shares
5,967
Price
$3.54
Total Value
$21.09K
Shares Held After
57,783
% of Holdings
9.4%
Neumora Therapeutics, Inc. Common Stock (NMRA)
Aurora Daljit Singh — Title: Chief Operating and Development Officer
Shares
6,165
Price
$3.56
Total Value
$21.92K
Shares Held After
82,770
% of Holdings
6.9%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
609
Price
$489.46
Total Value
$298.08K
Shares Held After
49,018
% of Holdings
1.2%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
7,989
Price
$46.53
Total Value
$371.71K
Shares Held After
106,929
% of Holdings
7.0%
Scholar Rock Holding Corp (SRRK)
Ho Junlin — GENERAL COUNSEL
Shares
9,580
Price
$46.53
Total Value
$445.74K
Shares Held After
241,545
% of Holdings
3.8%
Scholar Rock Holding Corp (SRRK)
Parlavecchio Caryn — CHRO
Shares
9,035
Price
$46.53
Total Value
$420.38K
Shares Held After
169,087
% of Holdings
5.1%
Scholar Rock Holding Corp (SRRK)
Marantz Jing L. — CHIEF MEDICAL OFFICER
Shares
4,157
Price
$46.53
Total Value
$193.42K
Shares Held After
126,012
% of Holdings
3.2%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
93
Price
$27.18
Total Value
$2.53K
Shares Held After
379,786
% of Holdings
0.0%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
3,272
Price
$26.29
Total Value
$86.04K
Shares Held After
379,879
% of Holdings
0.9%
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
Webster Brian Daniel — Director
Shares
11,635
Price
$25.39
Total Value
$295.46K
Shares Held After
383,151
% of Holdings
2.9%
Inotiv, Inc. (NOTV)
Leasure Robert Jr. — Director
Shares
16,810
Price
$0.30
Total Value
$4.96K
Shares Held After
1,256,215
% of Holdings
1.3%
Inotiv, Inc. (NOTV)
Sagartz John E — Chief Strategy Officer
Shares
2,119
Price
$0.29
Total Value
$616.21
Shares Held After
735,697
% of Holdings
0.3%
Inotiv, Inc. (NOTV)
Taylor Beth A. — Chief Financial Officer
Shares
2,888
Price
$0.29
Total Value
$845.90
Shares Held After
145,480
% of Holdings
1.9%
Showing 651–700 of 1586 transactions (page 14 of 32)